White Paper
COVID-19 and the "New Normal" for the MedTech Commercial Model
COVID-19 is changing the commercial landscape for the MedTech industry.
Jun 15, 2020

Wide-ranging disruptions are already taking shape, from those affecting interaction models to new regulatory guidance and more aggressive production capacities and timelines. Some of these changes are likely to be long-lasting and with this comes challenges as well as opportunities. It is critical to prepare by evaluating all available resources and move quickly toward positive change and innovation.

Related solutions

Contact Us